Franklin Genomic Advancements ETF Rating $28.06 +0.90 (+3.33%) Closing price 07/11/2025 03:58 PM EasternExtended Trading$28.06 0.00 (0.00%) As of 07/11/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Franklin Genomic Advancements ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HELX Aggregate RatingModerate Buy 2.76Holdings in HELX have an aggregate rating of Moderate Buy based on 661 analyst ratings issued in the past year covering 45 companies (85.0% of the portfolio).HELX Aggregate Price Target$28.06High Prediction$28.06Average Prediction$28.06Low Prediction$28.06Holdings in HELX have an aggregate price target of $28.06 and a range of $28.06 to $28.06 covering 45 companies (85.0% of the portfolio).HELX Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy30 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Franklin Genomic Advancements ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 45 HELX Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.46%NTRANatera$160.43-1.8%1.6524 of 5 stars3.00$184.63 15.1%154.16%VRTXVertex Pharmaceuticals$468.85-2.2%4.3239 of 5 stars2.54$511.62 9.1%28Positive NewsAnalyst Revision3.60%GHGuardant Health$50.25-2.0%4.116 of 5 stars3.00$53.76 7.0%213.56%ALNYAlnylam Pharmaceuticals$314.94-2.4%4.1804 of 5 stars2.80$345.70 9.8%25Positive NewsAnalyst Forecast3.54%MEDPMedpace$323.50-1.4%4.2753 of 5 stars2.21$344.82 6.6%14News CoverageAnalyst Revision3.38%KRYSKrystal Biotech$148.17-1.0%4.6697 of 5 stars3.00$213.75 44.3%9Trending NewsAnalyst ForecastInsider TradeAnalyst Revision3.33%CTVACorteva$73.50-1.8%4.2461 of 5 stars2.80$75.54 2.8%15Positive NewsAnalyst Forecast3.32%INSMInsmed$98.18+1.6%4.3684 of 5 stars3.00$108.07 10.1%17Positive NewsAnalyst ForecastInsider Trade3.23%LLYEli Lilly and Company$793.34+0.3%4.9813 of 5 stars2.75$1,012.56 27.6%20Trending NewsAnalyst ForecastAnalyst Revision2.88%UTHRUnited Therapeutics$295.52-1.5%4.9888 of 5 stars2.69$383.08 29.6%13News CoveragePositive NewsAnalyst Forecast2.86%BNTXBioNTech$112.89-0.9%1.6374 of 5 stars2.83$137.91 22.2%18News CoverageAnalyst Forecast2.79%AZNAstraZeneca$71.13-0.9%3.7571 of 5 stars2.83$89.00 25.1%6Positive NewsAnalyst Forecast2.54%REGNRegeneron Pharmaceuticals$567.74+1.4%4.8307 of 5 stars2.80$814.57 43.5%25Trending NewsAnalyst ForecastAnalyst Revision2.29%CDNSCadence Design Systems$320.60-0.6%4.5071 of 5 stars2.79$327.93 2.3%14Positive NewsAnalyst Forecast2.29%BBIOBridgeBio Pharma$46.47+0.4%4.6022 of 5 stars3.00$60.21 29.6%14Analyst Upgrade2.10%TMOThermo Fisher Scientific$435.02+1.0%4.9933 of 5 stars2.80$600.30 38.0%20Trending NewsDividend AnnouncementAnalyst ForecastAnalyst Revision1.91%RAREUltragenyx Pharmaceutical$29.51-4.9%3.954 of 5 stars2.93$85.36 189.2%14Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading Volume1.88%DHRDanaher$204.80-0.3%4.8944 of 5 stars2.85$248.43 21.3%20Positive NewsAnalyst Forecast1.84%EXASExact Sciences$51.91-2.6%4.7664 of 5 stars2.95$70.50 35.8%22Analyst Forecast1.79%ADPTAdaptive Biotechnologies$11.82-2.2%2.8825 of 5 stars2.86$10.57 -10.6%71.78%QGENQIAGEN$48.13-0.9%3.5769 of 5 stars2.30$49.40 2.6%101.72%TWSTTwist Bioscience$38.03-1.1%4.3843 of 5 stars2.70$50.40 32.5%10Gap Down1.70%TEMTempus AI$56.88-4.6%2.2898 of 5 stars2.50$65.09 14.4%12Trending NewsInsider Trade1.61%LGNDLigand Pharmaceuticals$121.70-2.6%4.0806 of 5 stars3.00$147.17 20.9%6News CoverageInsider Trade1.48%LHLabcorp$249.24-1.7%4.7122 of 5 stars2.57$276.38 10.9%14Trending NewsDividend AnnouncementAnalyst ForecastAnalyst Revision1.33%CRLCharles River Laboratories International$159.78-2.4%4.5625 of 5 stars2.25$174.54 9.2%16Positive NewsAnalyst Upgrade1.31%AAgilent Technologies$123.35-0.7%4.7482 of 5 stars2.54$139.77 13.3%13Analyst Forecast1.19%RGENRepligen$130.19-2.8%4.6645 of 5 stars2.69$170.75 31.2%13Positive NewsAnalyst Forecast1.16%NBIXNeurocrine Biosciences$133.46-1.1%4.5451 of 5 stars2.87$163.91 22.8%23Trending NewsAnalyst ForecastInsider TradeAnalyst Revision1.08%DOCSDoximity$60.26+0.3%2.3057 of 5 stars2.64$64.42 6.9%22Positive NewsAnalyst UpgradeInsider Trade1.06%GRALGRAIL$40.73-6.1%0.6503 of 5 stars2.25$31.50 -22.7%40.97%BMRNBioMarin Pharmaceutical$58.10-1.2%4.9453 of 5 stars2.75$93.61 61.1%24News CoveragePositive News0.91%CPRXCatalyst Pharmaceuticals$21.81-0.2%4.9341 of 5 stars3.25$32.83 50.5%8Positive News0.88%IQVIQVIA$162.73-1.7%4.9311 of 5 stars2.75$222.45 36.7%24Analyst ForecastAnalyst Revision0.85%VCYTVeracyte$27.08-1.6%3.5949 of 5 stars2.70$40.90 51.0%100.76%RXRXRecursion Pharmaceuticals$5.28-7.7%1.9991 of 5 stars2.33$7.00 32.6%6Analyst ForecastOptions VolumeGap Down0.75%RVTYRevvity$101.49-0.9%2.7667 of 5 stars2.73$123.07 21.3%15News CoverageAnalyst Forecast0.70%PTCTPTC Therapeutics$48.55-2.0%4.5686 of 5 stars2.67$65.00 33.9%15Positive News0.65%IONSIonis Pharmaceuticals$41.73-1.5%4.6661 of 5 stars2.78$58.25 39.6%18Positive News0.62%DVAXDynavax Technologies$10.58-2.9%4.3707 of 5 stars2.50$24.00 126.8%4News Coverage0.60%SDGRSchrodinger$21.01-3.2%1.9921 of 5 stars2.75$33.25 58.3%40.58%BEAMBeam Therapeutics$21.16-3.9%2.2592 of 5 stars3.00$48.75 130.4%15News Coverage0.57%BRKRBruker$43.79+0.5%4.8831 of 5 stars2.40$52.89 20.8%100.51%BMYBristol Myers Squibb$46.91-3.3%4.8892 of 5 stars2.32$57.69 23.0%22Trending NewsAnalyst ForecastAnalyst Revision0.50%CDNACareDx$20.13-2.4%4.2697 of 5 stars2.67$30.33 50.7%6Positive NewsInsider Trade This page (BATS:HELX) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Franklin Genomic Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Franklin Genomic Advancements ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HELX Stock Alerts